BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND TPR, P12270, 7175 AND Treatment
21 results:

  • 1. The insufficiency of CT examination in early detection of central lung squamous cell carcinoma and squamous epithelial precancerous lesions.
    Zhou J; Yu B; Guo P; Wang S
    BMC Cancer; 2024 Mar; 24(1):299. PubMed ID: 38443800
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. First exploration of the on-treatment changes in tumor and organ uptake of a radiolabeled anti PD-L1 antibody during chemoradiotherapy in patients with non-small cell lung cancer using whole body PET.
    Pouw JEE; Hashemi SMS; Huisman MC; Wijngaarden JE; Slebe M; Oprea-Lager DE; Zwezerijnen GJC; Vugts D; Ulas EB; de Gruijl TD; Radonic T; Senan S; Menke-van der Houven van Oordt CW; Bahce I
    J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38302416
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Deep pathomics: A new image-based tool for predicting response to treatment in stage III non-small cell lung cancer.
    Nibid L; Greco C; Cordelli E; Sabarese G; Fiore M; Liu CZ; Ippolito E; Sicilia R; Miele M; Tortora M; Taffon C; Rakaee M; Soda P; Ramella S; Perrone G
    PLoS One; 2023; 18(11):e0294259. PubMed ID: 38015944
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comparison of the accuracy of Monte Carlo and Ray Tracing dose calculation algorithms for multiple target brain treatments on CyberKnife.
    Mukwada G; Skorska M; Rowshanfarzad P; Ebert MA
    Phys Eng Sci Med; 2023 Dec; 46(4):1477-1487. PubMed ID: 37552365
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Construction and validation of a T cell proliferation regulator-related signature for predicting prognosis and immunotherapy response in lung adenocarcinoma.
    Chang W; Li H; Cheng Y; He H; Ou W; Wang SY
    Front Immunol; 2023; 14():1171145. PubMed ID: 37081889
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Discovery of D6808, a Highly Selective and Potent Macrocyclic c-Met Inhibitor for Gastric cancer Harboring
    Wang C; Li J; Qu L; Tang X; Song X; Yang F; Chen X; Lin Q; Lin W; Zhou Y; Tu Z; Chen Y; Zhang Z; Lu X
    J Med Chem; 2022 Nov; 65(22):15140-15164. PubMed ID: 36355693
    [No Abstract]    [Full Text] [Related]  

  • 7. Ttc39c is a potential target for the treatment of lung cancer.
    Rong H; Peng J; Ma K; Zhu J; He JT
    BMC Pulm Med; 2022 Oct; 22(1):391. PubMed ID: 36303158
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical Utility of Next-generation Sequencing in Real-world Cases: A Single-institution Study of Nine Cases.
    Kim M; Jeong JY; Park NJ; Park JY
    In Vivo; 2022; 36(3):1397-1407. PubMed ID: 35478134
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Combination of Type I and Type II MET Tyrosine Kinase Inhibitors as Therapeutic Approach to Prevent Resistance.
    Bahcall M; Paweletz CP; Kuang Y; Taus LJ; Sim T; Kim ND; Dholakia KH; Lau CJ; Gokhale PC; Chopade PR; Hong F; Wei Z; Köhler J; Kirschmeier PT; Guo J; Guo S; Wang S; Jänne PA
    Mol Cancer Ther; 2022 Feb; 21(2):322-335. PubMed ID: 34789563
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The effectiveness of generic emails versus a remote knowledge broker to integrate mood management into a smoking cessation programme in team-based primary care: a cluster randomised trial.
    Minian N; Ahad S; Ivanova A; Veldhuizen S; Zawertailo L; Ravindran A; de Oliveira C; Baliunas D; Mulder C; Bolbocean C; Selby P
    Implement Sci; 2021 Mar; 16(1):30. PubMed ID: 33743777
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Evidence of NTRK1 Fusion as Resistance Mechanism to EGFR TKI in EGFR+ NSCLC: Results From a Large-Scale Survey of NTRK1 Fusions in Chinese Patients With lung cancer.
    Xia H; Xue X; Ding H; Ou Q; Wu X; Nagasaka M; Shao YW; Hu X; Ou SI
    Clin Lung Cancer; 2020 May; 21(3):247-254. PubMed ID: 31761448
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Quality assurance of Cyberknife robotic stereotactic radiosurgery using an angularly independent silicon detector.
    Alhujaili SF; Biasi G; Alzorkany F; Grogan G; Al Kafi MA; Lane J; Hug B; Aldosari AH; Alshaikh S; Farzad PR; Ebert MA; Moftah B; Rosenfeld AB; Petasecca M
    J Appl Clin Med Phys; 2019 Jan; 20(1):76-88. PubMed ID: 30565856
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Stability of the cancer target DDIAS is regulated by the CHIP/HSP70 pathway in lung cancer cells.
    Won KJ; Im JY; Kim BK; Ban HS; Jung YJ; Jung KE; Won M
    Cell Death Dis; 2017 Jan; 8(1):e2554. PubMed ID: 28079882
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A novel fusion of tpr and ALK in lung adenocarcinoma.
    Choi YL; Lira ME; Hong M; Kim RN; Choi SJ; Song JY; Pandy K; Mann DL; Stahl JA; Peckham HE; Zheng Z; Han J; Mao M; Kim J
    J Thorac Oncol; 2014 Apr; 9(4):563-6. PubMed ID: 24736082
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Resection and heated pleural chemoperfusion in patients with thymic epithelial malignant disease and pleural spread: a single-institution experience.
    Yellin A; Simansky DA; Ben-Avi R; Perelman M; Zeitlin N; Refaely Y; Ben-Nun A
    J Thorac Cardiovasc Surg; 2013 Jan; 145(1):83-7; discussion 87-9. PubMed ID: 23111024
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Designed hybrid tpr peptide targeting Hsp90 as a novel anticancer agent.
    Horibe T; Kohno M; Haramoto M; Ohara K; Kawakami K
    J Transl Med; 2011 Jan; 9():8. PubMed ID: 21235734
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Independent calculation of dose from a helical TomoTherapy unit.
    Gibbons JP; Smith K; Cheek D; Rosen I
    J Appl Clin Med Phys; 2009 Feb; 10(1):103-119. PubMed ID: 19223830
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Absence of cancer diagnosis and treatment in elderly Medicaid-insured nursing home residents.
    Bradley CJ; Clement JP; Lin C
    J Natl Cancer Inst; 2008 Jan; 100(1):21-31. PubMed ID: 18159068
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A selective small molecule c-MET Inhibitor, PHA665752, cooperates with rapamycin.
    Ma PC; Schaefer E; Christensen JG; Salgia R
    Clin Cancer Res; 2005 Mar; 11(6):2312-9. PubMed ID: 15788682
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
    Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R
    Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.